Last edition
News about "clinical trials of KLTO-202"
Klotho Neurosciences Advances Gene Therapy Manufacturing for ALS Treatment
Klotho Neurosciences has announced the initiation of manufacturing and process development for KLTO-202, its investigational gene therapy targeting ALS, with plans to begin clinical trials by Q3 next year.
Clinical Trials Of KLTO-202 | 02/07/2025 | By Mrinmoy Dey | 202
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members